193 related articles for article (PubMed ID: 35636517)
1. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
2. Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA; Giaccia AJ
Nat Rev Drug Discov; 2011 May; 10(5):351-64. PubMed ID: 21532565
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.
Wang J; Yu L; Jiang H; Zheng X; Zeng S
Drug Metab Dispos; 2020 Sep; 48(9):759-768. PubMed ID: 32601104
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Lethal Interactions in Cancer Therapy.
Geng X; Wang X; Zhu D; Ying S
Curr Cancer Drug Targets; 2017; 17(4):304-310. PubMed ID: 27113746
[TBL] [Abstract][Full Text] [Related]
5. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
6. Role of Drug-metabolizing Enzymes in Cancer and Cancer Therapy.
Feng S; Li A; Zheng YC; Liu HM
Curr Drug Metab; 2020; 21(1):67-76. PubMed ID: 31902352
[TBL] [Abstract][Full Text] [Related]
7. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
8. Complex synthetic lethality in cancer.
Ryan CJ; Devakumar LPS; Pettitt SJ; Lord CJ
Nat Genet; 2023 Dec; 55(12):2039-2048. PubMed ID: 38036785
[TBL] [Abstract][Full Text] [Related]
9. Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma.
Tang L; Chen R; Xu X
Cancer Lett; 2020 Apr; 476():120-128. PubMed ID: 32070778
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lethality screens point the way to new cancer drug targets.
Mullard A
Nat Rev Drug Discov; 2017 Sep; 16(9):589-591. PubMed ID: 28860588
[No Abstract] [Full Text] [Related]
11. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
12. A lethal combination for cancer cells: synthetic lethality screenings for drug discovery.
Ferrari E; Lucca C; Foiani M
Eur J Cancer; 2010 Nov; 46(16):2889-95. PubMed ID: 20724143
[TBL] [Abstract][Full Text] [Related]
13. Overview of Ferroptosis and Synthetic Lethality Strategies.
Kinowaki Y; Taguchi T; Onishi I; Kirimura S; Kitagawa M; Yamamoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502181
[TBL] [Abstract][Full Text] [Related]
14. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Topatana W; Juengpanich S; Li S; Cao J; Hu J; Lee J; Suliyanto K; Ma D; Zhang B; Chen M; Cai X
J Hematol Oncol; 2020 Sep; 13(1):118. PubMed ID: 32883316
[TBL] [Abstract][Full Text] [Related]
15. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?
Canaani D
Cancer Lett; 2014 Sep; 352(1):59-65. PubMed ID: 23962561
[TBL] [Abstract][Full Text] [Related]
16. A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality.
Parameswaran S; Kundapur D; Vizeacoumar FS; Freywald A; Uppalapati M; Vizeacoumar FJ
Trends Cancer; 2019 Jan; 5(1):11-29. PubMed ID: 30616753
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibition as a prototype for synthetic lethal screens.
Liu X
Methods Mol Biol; 2013; 986():123-37. PubMed ID: 23436410
[TBL] [Abstract][Full Text] [Related]
18. Synthetic Lethality - Its Current Application and Potential in Oncological Treatment.
Bortlíková L; Müller P; Vojtěšek B; Rak V; Svoboda M
Klin Onkol; 2019; 32(Supplementum 3):19-24. PubMed ID: 31627702
[TBL] [Abstract][Full Text] [Related]
19. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; Sliwiński T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
20. Synthetic lethality: emerging targets and opportunities in melanoma.
Thompson N; Adams DJ; Ranzani M
Pigment Cell Melanoma Res; 2017 Mar; 30(2):183-193. PubMed ID: 28097822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]